KERALA AYURVEDA LTD.

Kerala Ayurveda Ltd has announced its 34th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 11:00 am IST. The meeting will be conducted via Video Conference (VC)/ Other Audio Visual Means (OAVM) in compliance with current regulations. The notice and the Annual Report for the financial year 2025-26 are being disseminated electronically to shareholders and will also be available on the BSE website, CDSL's e-voting portal, and the company's website. A cut-off date of September 21, 2026, has been set for determining voting rights, with remote e-voting available from September 25 to September 27, 2026.

Kerala Ayurveda Limited has announced its 34th Annual General Meeting (AGM) will be held on Monday, September 28, 2026, at 11:00 am IST via Video Conference (VC)/Other Audio Visual Means (OAVM). This is in compliance with the Companies Act, 2013, and relevant MCA and SEBI circulars. The Annual Report for FY 2025-26 and the AGM Notice are being disseminated via email to shareholders and will be available on the BSE website, CDSL's e-voting portal, and the company's website. The cut-off date for voting eligibility is September 21, 2026. Remote e-voting will be open from September 25 to September 27, 2026.

The Board of Directors of Kerala Ayurveda Limited has approved a preferential issue of up to 7,20,000 equity shares, each with a face value of Rs. 10, at a price of Rs. 190.37 per share. This issuance, aggregating to Rs. 13,70,66,400, is for the conversion of an outstanding unsecured loan from Katra Holding Private Limited, a promoter group entity. The move is subject to shareholder approval and other regulatory requirements. The company also announced the convening of its 34th Annual General Meeting on September 28, 2026, to seek shareholder consent for this preferential issue.

Kerala Ayurveda Ltd has announced a Board of Directors meeting scheduled for September 4, 2026. The primary agenda items include considering and approving a preferential issue of equity shares, subject to regulatory approvals. Additionally, the board will convene the 34th Annual General Meeting on September 28, 2026, to be held via Video Conferencing. The trading window for designated persons has been closed and will reopen 48 hours after the outcome of the board meeting is announced.

Kerala Ayurveda Limited's Board of Directors met on August 12, 2026, approving the unaudited financial results for Q2 2026 with an unmodified auditor's report. A significant decision was the approval of a Scheme of Amalgamation to merge its wholly-owned subsidiary, Ayurvedagram Heritage Wellness Centre Private Limited, with the company. This merger aims to integrate operations, reduce overheads, and rationalize the legal entity structure. The board also approved the re-appointment of Mr. Ramesh Vangal as Non-Executive Director and the grant of 64,875 Employee Stock Options (ESOPs) under the Kerala Ayurveda Employee Restricted Stock Unit Plan, 2023. The amalgamation is subject to shareholder, NCLT, and regulatory approvals.

Kerala Ayurveda Ltd (KAL) announced its Q1 FY27 financial results, reaffirming its Vision 2030 target of scaling consolidated revenue to ₹1000 Crs by FY30. The company reported a 16.0% YoY increase in Revenue from Operations to ₹33.2 Crs. The Operating EBITDA (Adj.) loss halved sequentially to ₹-3.82 Crs from ₹-7.10 Crs in Q4 FY26, indicating progress in its transformation agenda. Key growth drivers include a 32.3% YoY increase in Global E-Product sales and a 28.3% YoY rise in Standalone business revenue. KAL is focused on operational efficiencies, leaner spending, and achieving Operating EBITDA breakeven by September 2026, supported by strategic investments in capacity, talent, and technology.

Kerala Ayurveda Limited announced that its Board of Directors, in a meeting held on August 12, 2026, approved the unaudited financial results for the quarter ended June 30, 2026 (both standalone and consolidated). The board also approved a Scheme of Amalgamation between Ayurvedagram Heritage Wellness Centre Private Limited and Kerala Ayurveda Limited, subject to shareholder and regulatory approvals. Additionally, the Nomination and Remuneration Committee approved the grant of 64,875 Employee Stock Options (ESOPs). Mr. Ramesh Vangal was re-appointed as Non-Executive Director.

Kerala Ayurveda Limited's Board of Directors met on August 12, 2026, approving the unaudited financial results for the quarter ended June 30, 2026 (standalone and consolidated) with an unmodified auditor's report. The board also approved a scheme of amalgamation between the company and its wholly-owned subsidiary, Ayurvedagram Heritage Wellness Centre Private Limited, subject to shareholder and regulatory approvals. Additionally, Mr. Ramesh Vangal was re-appointed as Non-Executive Director, and 64,875 Employee Stock Options (ESOPs) were approved for eligible employees.

Kerala Ayurveda Ltd has announced that its Board of Directors will convene on August 12, 2026. The primary agenda item for this meeting is to consider and approve the unaudited financial results, both standalone and consolidated, for the quarter that concluded on June 30, 2026. Additionally, the company has informed about the closure of the trading window for designated persons from June 30, 2026, which will reopen 48 hours after the results are publicly disclosed, in compliance with SEBI regulations.

Kerala Ayurveda Ltd has announced the closure of its trading window for designated persons and their immediate relatives. This closure will be effective from Tuesday, June 30, 2026, and will remain in effect for 48 hours after the announcement of the unaudited financial results for the quarter ending June 30, 2026. The company will separately announce the date of the Board of Directors' meeting to approve these results. In line with SEBI regulations, the PAN of designated persons and their relatives will be frozen for trading during this period.